These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1967337)

  • 1. Metolazone in treatment of severe refractory congestive cardiac failure.
    Kiyingi A; Field MJ; Pawsey CC; Yiannikas J; Lawrence JR; Arter WJ
    Lancet; 1990 Jan; 335(8680):29-31. PubMed ID: 1967337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of furosemide and metolazone in the treatment of severe congestive heart failure.
    Grosskopf I; Rabinovitz M; Rosenfeld JB
    Isr J Med Sci; 1986 Nov; 22(11):787-90. PubMed ID: 3793436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination diuretic treatment in severe heart failure: a randomised controlled trial.
    Channer KS; McLean KA; Lawson-Matthew P; Richardson M
    Br Heart J; 1994 Feb; 71(2):146-50. PubMed ID: 8130022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metolazone in the treatment of refractory heart insufficiency. Experience of 10 cases].
    Kirancumar ; Loureiro PA; Correia JM
    Rev Port Cardiol; 1989 Nov; 8(11):775-8. PubMed ID: 2631826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with metolazone and loop diuretics in outpatients with refractory heart failure: an observational study and review of the literature.
    Rosenberg J; Gustafsson F; Galatius S; Hildebrandt PR
    Cardiovasc Drugs Ther; 2005 Aug; 19(4):301-6. PubMed ID: 16189620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing the sodium excreting efficacy of furosemide and indapamide combination against furosemide and metolazone combination in congestive heart failure patients: A randomized control trial.
    Salahudin M; Shah H; Jan MU; Altaf A
    J Pak Med Assoc; 2019 Dec; 69(12):1794-1799. PubMed ID: 31853105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metolazone in the treatment of advanced therapy-resistant dilated cardiomyopathy].
    Kröger N; Szuba J; Frenzel H
    Med Klin (Munich); 1991 Jun; 86(6):305-8, 332. PubMed ID: 1886511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Intravenous Chlorothiazide versus Oral Metolazone in Patients with Acute Decompensated Heart Failure and Loop Diuretic Resistance.
    Shulenberger CE; Jiang A; Devabhakthuni S; Ivaturi V; Liu T; Reed BN
    Pharmacotherapy; 2016 Aug; 36(8):852-60. PubMed ID: 27393709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metolazone and spironolactone in cirrhosis and the nephrotic syndrome.
    Lang GR; Westenfelder C; Nascimento L; Dhupelia VB; Arruda JA; Kane RE
    Clin Pharmacol Ther; 1977 Feb; 21(2):234-43. PubMed ID: 319937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Intravenous Chlorothiazide for Refractory Acute Decompensated Heart Failure Unresponsive to Adjunct Metolazone.
    Cardinale M; Altshuler J; Testani JM
    Pharmacotherapy; 2016 Aug; 36(8):843-51. PubMed ID: 27321568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term diuretic therapy with metolazone of renal failure and the nephrotic syndrome.
    Paton RR; Kane RE
    J Clin Pharmacol; 1977 Apr; 17(4):243-51. PubMed ID: 849998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metolazone for severe dilated cardiomyopathy refractory to conventional therapy.
    Kröger N; Szuba J; Buhl C; Pompecki R; Frenzel H
    Lancet; 1990 Apr; 335(8696):1031-2. PubMed ID: 1970077
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe electrolyte disturbances associated with metolazone and furosemide.
    Black WD; Shiner PT; Roman J
    South Med J; 1978 Apr; 71(4):380-1, 385. PubMed ID: 635611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diuresis Efficacy in Ambulatory Congested Heart Failure Patients: Intrapatient Comparison of 3 Diuretic Regimens (DEA-HF).
    Abbo AR; Gruber A; Volis I; Aronson D; Girerd N; Lund Kristensen S; Zukermann R; Alberkant N; Sitnitsky E; Kruger A; Khasis P; Bravo E; Elad B; Helmer Levin L; Caspi O
    JACC Heart Fail; 2024 Aug; 12(8):1396-1405. PubMed ID: 38739124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diuretic Strategies for Loop Diuretic Resistance in Acute Heart Failure: The 3T Trial.
    Cox ZL; Hung R; Lenihan DJ; Testani JM
    JACC Heart Fail; 2020 Mar; 8(3):157-168. PubMed ID: 31838029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of metolazone versus chlorothiazide in acute decompensated heart failure with diuretic resistance.
    Moranville MP; Choi S; Hogg J; Anderson AS; Rich JD
    Cardiovasc Ther; 2015 Apr; 33(2):42-9. PubMed ID: 25712736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of premenstrual tension with metolazone: a double-blind evaluation of a new diuretic.
    Werch A; Kane RE
    Curr Ther Res Clin Exp; 1976 Jun; 19(6):565-72. PubMed ID: 819215
    [No Abstract]   [Full Text] [Related]  

  • 18. Antihypertensive efficacy of metolazone (Zaroxolyn) alone and combined with reserpine in treatment of essential hypertension.
    Van Hoose MC; Cutler RE
    Curr Ther Res Clin Exp; 1976 Sep; 20(3):266-76. PubMed ID: 822985
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of bumetanide- and metolazone-based diuretic regimens to furosemide in acute heart failure.
    Ng TM; Konopka E; Hyderi AF; Hshieh S; Tsuji Y; Kim BJ; Han SY; Phan DH; Jeng AI; Lou M; Elkayam U
    J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):345-53. PubMed ID: 23538300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metolazone and its role in edema management.
    Sica DA
    Congest Heart Fail; 2003; 9(2):100-5. PubMed ID: 12671341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.